Für den Inhalt der Angaben zeichnet die Projektleitung verantwortlich.
Dieses von der Gebert Rüf Stiftung geförderte Projekt wird von folgenden weiteren Projektpartnern mitgetragen:
Förderbeitrag: CHF 150'000
Dauer: 07.2023 - 06.2024
InnoBooster, seit 2018
Dr. Thomas Lumpe
8092 Zürich (Schweiz)
Low- and Middle-Income Countries (LMICs) lack a sufficient supply of medical ventilators leading to millions of preventable deaths and poor patient outcomes each year. This is further exacerbated by the drastic population growth especially in LMICs and ageing societies across the world.
To address this problem, we develop a ventilator for emergency use, transport, and short-term critical care. For the successful introduction into the market and a sustainable use in low-resource settings, we take a holistic, user-centered approach to design a ventilator that is intuitive to use, robust, and easy to maintain, even in harsh environments. In collaboration with our medical partners, we focus on safe patient care by integrating the ventilator in a training platform to promote medical and technical knowledge in low-resource settings and make the use of our ventilator more accessible. We continuously validate our solution with local stakeholders and experts from all around the world. Eventually, we would like to co-produce the ventilator locally to promote knowledge exchange, strengthen local economies, and build capacity.
As such, we believe that our ventilator can be both an essential piece of medical equipment to advance the state of healthcare in LMICs and a pioneering device that demonstrates how sustainable solutions for essential medical care in challenging settings can be created.
The InnoBooster funding helps us to take the next big step with our validated proof-of-concept ventilator prototype towards pilot production, which is necessary on our path to regulatory certification. It will specifically advance our hardware and controls development following regulatory guidelines, as well as support the planning of a pilot production. To ensure the efficiency and appropriate use of our solution, we continuously validate it together with local stakeholders and experts. As such, by helping us to translate our innovative technology from Swiss academia to global markets, the InnoBooster funding can help us to create real-world impact for underserved patients in low-resource setting.
Am Projekt beteiligte Personen
Letzte Aktualisierung dieser Projektdarstellung 13.07.2023